The Liver-Selective Thyromimetic T-0681 Influences Reverse Cholesterol Transport and Atherosclerosis Development in Mice

Ivan Tancevski, Egon Demetz, Philipp Eller et al. · 2010

Read The Liver-Selective Thyromimetic T-0681 Influences Reverse Cholesterol Transport and Atherosclerosis Development in Mice by Ivan Tancevski, Egon Demetz, Philipp Eller et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0008722.txt.

Description

Ivan Tancevski, Egon Demetz, Philipp Eller, and colleagues tested a thyroid-like drug aimed only at the liver. Their mouse study appeared in PLOS ONE in 2010. The compound, T-0681, mimics thyroid hormone in liver tissue. Such drugs can raise receptors that pull cholesterol from the blood. A liver-only action might spare the heart from thyroid side effects.

The team measured reverse cholesterol transport, the path that carries cholesterol out for disposal. They also watched artery plaque build-up in treated mice. Better transport paired with slower plaque growth would support the approach. The study weighs promise against the risks of thyroid mimicry.

Catalog record

CREATORIvan Tancevski, Egon Demetz, Philipp Eller et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008722

Browse the full library · About the Tower of Babel